Labcorp (LH) CEO sells 5,745 shares at $262.75 under 10b5-1
Labcorp (LH) reported an insider transaction by President & CEO and Director Adam H. Schechter.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Labcorp (LH) reported an insider transaction by President & CEO and Director Adam H. Schechter. On 11/11/2025, he sold 5,745 shares of common stock at $262.75 per share, as disclosed on Form 4.
The transaction was made pursuant to a Rule 10b5-1 trading plan. Following the sale, Schechter beneficially owns 87,574 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,745 | $262.75 | $1.51M |
Footnotes (1)
- F1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Labcorp (LH) disclose in this Form 4?
Was the LH insider trade under a 10b5-1 plan?
What is the insider’s relationship to Labcorp (LH)?
What was the transaction code on the Form 4?
Was ownership direct or indirect after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.